"We are seeing people delay routine care, preventive care." ...
Cipla aims to achieve $1 billion in revenue in North America in the financial year 2027.
A case report describes how an adolescent girl with an invasive growth hormone-secreting pituitary tumor achieved biochemical ...
Point72 Asset Management is back as a public short seller in pharmaceutical company Camurus, according to the Swedish Financial Supervisory Authority's register. There are three public short sellers ...
OPKO Health's OPKO Biologics unit said Tuesday the first participant has been dosed in a phase 1/2a trial of OPK-8801001 in acromegaly, a rare endocrine disorder caused by excess ...
کاڵیی مەزن، ئەفسانەی زۆرانبازیی WWE لە نوێترین دەرکەوتنیدا لەلایەن کامێراکانەوە وێنەی گیرا و بەشداری لە چەند ئاهەنگێکی ...